References
- M. Gibaldi, The number of drugs administered buccally is increasing, Clin. Pharmacol.3 (1985) 49-56.
- D. Harris and J. R. Robinson, Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci.81 (1992) 1-10.
- S. Senel and A. A. Hincal, Drug penetration enhancement via buccal route: possibilities and limitations, J. Control. Rel.72 (2001) 133-144; DOI: 10.1016/SOI68-3659(01)00269-3
- S. S. Davis, P. B. Daly, J. W. Kennerley, M. Frier and C. G. Wilson, Design and Evaluation of Sustained Release Formulations for Oral and Buccal Administration, in Controlled Release Nitroglycerine in Buccal and Oral Form (Eds. W. D. Bussmann, R. R. Dries and W. Wagner, Karger, Basle 1982, pp. 17-25.
- T. S. Owens, R. J. Dansereau and A. Sakr, Development and evaluation of extended release bioadhesive sodium fluoride tablets, Int. J. Pharm.288 (2005) 109-122; DOI: 10.1016/j.ijpharm.2004. 09.017.
- J. Akbari, A. Nokhodchi, D. Farid, M. Adrangui, M. R. Siahi-Shadbad and M. Saeedi, Development and evaluation of buccoadhesive propranolol hydrochloride tablet formulations: effect of fillers, Farmaco59 (2004) 155-161.
- M. Ishida, N. Vambu and R. Vagai, Highly viscous gel ointment containing carbopol for application to the oral mucosa, Chem. Pharm. Bull.31 (1983) 4561-4564.
- M. Packer, A. J. S. Coats, M. B. Fowler, H. A. Katus, H. Krum, P. Mohacsi, J. L. Rouleau, M. T. Endera, A. Castaigne, E. B. Roecker, M. K. Schultz and D. L. Demets, Effect of carvedilol on survival, in severe chronic heart failur, N. Engl. J. Med.344 (2001) 1651-1658.
- J. H. Guo, Bioadhesive polymer buccal patches for buprenorphine controlled delivery formulation, in vitro adhesion and release properties, Drug Dev. Ind. Pharm.20 (1994) 2809-2821.
- R. Anders and H. P. Merkle, Evaluation of laminated mucoadhesive patches for buccal drug delivery, Int. J. Pharm.49 (1989) 231-240
- M. Packer, A. J. S. Coats, M. B. Fowler, H. A. Katus, M. B. Henry Krum, M. Paul, L. R. Jean, T. Michal, C. Alain, B. R. Ellen, K. S. Melissa, S. Christoph, L. C. Ellen and L. D. David, Effect of carvedilol on the morbidity of patients with severe chronic heart failure, Circulation106 (2002) 2194-2199.
- T. Morgan, Clinical pharmacokinetics and pharmacodynamics of carvedilol, Clin. Pharmacokinet.26 (1994) 335-346.
- Y. Vamshi Vishnu, K. Chandrasekhar, G. Ramesh and Y. Madhusudan Rao, Development of mucoadhesive patches for buccal administration of carvedilol, Curr. Drug Del.4 (2006) 27-39.
- United States Pharmacopeia 28, National Formulary 23, United States Pharmacopeial Convention, Rockville, 2005, pp. 2745.
- C. F. Wong, K. H. Yuen and K. Peh, An in vitro method for buccal adhesion studies: Importance of instrument variables, Int. J. Pharm.180 (1999) 47-57; DOI: 10.1016/SO378-5173(98).
- V. Agarwal and B. Mishra, Design, development and biopharmaceutical properties of buccoadhesive compacts of pentazocine, Drug Dev. Ind. Pharm.25 (1999) 701-709; DOI: 10.1081/DDC - 100102229.
- R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydro-matrices and other factors may be responsible, Int. J. Pharm.15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.
- N. A. Peppas, Analysis of Fickian and non-Fickian drug matrix tablets with respect to the compression force release from polymers, Pharm. Acta Helv.60 (1985) 110-111.
- D. A. van Eyk and P. van der Bijl, Comparative permeability of various chemical markers through human vaginal and buccal mucosa as well as porcine buccal and mouth floor mucosa, Arch. Oral Biol.49 (2004) 387-392; DOI: 10.1016/j.archoralbio.2003.12.002.
- C. A. Squier, P. Cox and P. W. Wertz, Lipid content and water permeability of skin and oral mucosa, J. Invest. Dermat.96 (1991) 123-126.